Pfizer and Shire last month were dragged into an ongoing patent-infringement lawsuit filed by Isis Pharmaceuticals against Santaris Pharma, with Isis asking for a court order to force the two drug makers to provide information it claims is relevant to the legal proceedings.

In court filings obtained by Gene Silencing News, Isis alleged that Pfizer and Shire, which partnered with Santaris to develop locked nucleic acid-based therapeutics, have neglected to provide subpoenaed documents in a timely manner.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.